These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15727003)

  • 1. Can drug patents be morally justified?
    Sterckx S
    Sci Eng Ethics; 2005 Jan; 11(1):81-92. PubMed ID: 15727003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are pharmaceutical patents protected by human rights?
    Millum J
    J Med Ethics; 2008 Nov; 34(11):e25. PubMed ID: 18974405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patents and access to drugs in developing countries: an ethical analysis.
    Sterckx S
    Dev World Bioeth; 2004 May; 4(1):58-75. PubMed ID: 15086374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Justifying a morally permissible breach of contract: kantian ethics, nozickian justice, and vaccine patents.
    Cordeiro-Rodrigues L
    Med Health Care Philos; 2023 Dec; 26(4):573-581. PubMed ID: 37479910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
    Resnik DB; DeVille KA
    Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852
    [No Abstract]   [Full Text] [Related]  

  • 6. Patents and the obligation to protect health: examining the significance of human rights considerations in the protection of pharmaceutical patents.
    Owoeye OA
    J Law Med; 2014 Jun; 21(4):900-19. PubMed ID: 25087369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dilemma of intellectual property rights for pharmaceuticals: the tension between ensuring access of the poor to medicines and committing to international agreements.
    Cohen JC; Illingworth P
    Dev World Bioeth; 2003 May; 3(1):27-48. PubMed ID: 14577451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intellectual property and pharmaceutical drugs: an ethical analysis.
    De George RT
    Bus Ethics Q; 2005 Oct; 15(4):549-75. PubMed ID: 16358442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patents and human rights: a heterodox analysis.
    Gold ER
    J Law Med Ethics; 2013; 41(1):185-98. PubMed ID: 23581665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to affordable HIV/AIDS drugs: the human rights obligations of multinational pharmaceutical corporations.
    Ferreira L
    Fordham Law Rev; 2002 Dec; 71(3):1133-79. PubMed ID: 12523370
    [No Abstract]   [Full Text] [Related]  

  • 11. Balancing access to pharmaceuticals with patent rights.
    Nicol D
    Monash Bioeth Rev; 2003 Apr; 22(2):50-62. PubMed ID: 15069957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intellectual property and biotechnology: the European debate.
    Brody B
    Kennedy Inst Ethics J; 2007 Jun; 17(2):69-110. PubMed ID: 18018994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent immorality?
    Bloche MG; Jungman ER
    Am J Bioeth; 2002; 2(3):48-9. PubMed ID: 12230859
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethical reasons for narrowing the scope of biotech patents.
    Andreassen T
    Med Health Care Philos; 2015 Nov; 18(4):463-73. PubMed ID: 25968142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
    Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
    Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical patents: reconciling the human right to health with the incentive to invent.
    Khachigian LM
    Drug Discov Today; 2020 Jul; 25(7):1135-1141. PubMed ID: 32325020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing drugs for the developing world: an economic, legal, moral, and political dilemma.
    Resnik DB
    Dev World Bioeth; 2001 May; 1(1):11-32. PubMed ID: 12870505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction: Access to life-saving medicines and intellectual property rights.
    Schroeder D
    Camb Q Healthc Ethics; 2011 Apr; 20(2):277-8. PubMed ID: 21435302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.